Overview

A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults

Status:
Recruiting

Trial end date:
2024-09-05

Target enrollment:

Participant gender:

Summary

The purpose of this clinical trial is to learn if the study medicine (called PF-07976016) is safe and how it goes in and out of the body in healthy people. The study may also explore if PF-07976016 has the potential to interact with another medicine called midazolam. In addition, the study may explore how PF-07976016 goes into the body of people who have obesity.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Midazolam